SVA [SINOVAC BIOTECH] 20-F: CONTENTS

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 20-F, Date: 2020-04-30, XBRL Interactive Financials
Original SEC Filing: Click here


Webplus: SVA/20200430/20-F/1/000.htm SEC Original: sva-20f_20191231.htm
CONTENTS




Webplus: SVA/20200430/20-F/2_EX-2.1/000.htm SEC Original: sva-ex21_658.htm
SPECIMEN * NOT VALID UNLESS COUNTERSIGNED BY TRANSFER AGENT * INCORPORATED UNDER THE LAWS OF THE GOVERNMENT OF ANTIGUA Number Sinovac Shares BIOTECH LTD. This Certifies that Is the Owner of Fully paid and non-assessable shares of Common Stock of Sinovac Biotech Ltd. transferable on the books of the Corporation in person or by attorney upon surrender of this certificate




Webplus: SVA/20200430/20-F/3_EX-2.2/000.htm SEC Original: sva-ex22_657.htm
SPECIMEN sinovac biotech, ltd NUMBER incorporated under the laws of the government of antigua not valid unless countersigned by transfer agent SHARES This certifies that is the record holder of FULLY PAID AND NON-ASSESSABLE SHARES OF PREFERRED SERIES “B” STOCK OF SINOVAC BIOTECH, LTD DATED SECRETARY PRESIDENT COUNTERSIGNED PACIFIC STOCK TRANSFER COMPANY Las Vegas, Nevada EX-2.2 3 sva-ex22_657.htm EX-2.2




Webplus: SVA/20200430/20-F/4_EX-2.3/000.htm SEC Original: sva-ex23_867.htm
Sinovac Biotech Ltd. (the “Company”) is an Antiguan company (Company No. 11949) with limited liability and its affairs are governed by its articles of incorporation and by-laws and the International Business Corporations Act. Prior to February 22, 2019, the Company’s common shares was listed on The Nasdaq Stock Market LLC (“Nasdaq”) under the symbol “SVA.” Since February 22, 2019, trading




Webplus: SVA/20200430/20-F/5_EX-8.1/000.htm SEC Original: sva-ex81_14.htm
List of Subsidiaries Sinovac Biotech (Hong Kong) Ltd., a Hong Kong company 1. Sinovac Biotech Co., Ltd., a PRC company 2. Sinovac Research & Development Co., Ltd., a PRC company 3. Sinovac (Dalian) Vaccine Technology Co., Ltd., a PRC company 4. Sinovac Biomed Co., Ltd., a PRC company 5. EX-8.1 5 sva-ex81_14.htm EX-8.1




Webplus: SVA/20200430/20-F/6_EX-12.1/000.htm SEC Original: sva-ex121_8.htm
CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER I, Weidong Yin, certify that: 1. 2. 3. 4. (a) (b) (c) (d) 5. (a) (b) Weidong Yin Chairman and Chief Executive Officer EX-12.1 6 sva-ex121_8.htm EX-12.1




Webplus: SVA/20200430/20-F/7_EX-12.2/000.htm SEC Original: sva-ex122_7.htm
CERTIFICATION BY THE CHIEF FINANCIAL OFFICER I, Nan Wang, certify that: 1. 2. 3. 4. (a) (b) (c) (d) 5. (a) (b) Nan Wang Chief Financial Officer EX-12.2 7 sva-ex122_7.htm EX-12.2




Webplus: SVA/20200430/20-F/8_EX-13.1/000.htm SEC Original: sva-ex131_9.htm
CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER (1) (2) Weidong Yin Chairman and Chief Executive Officer EX-13.1 8 sva-ex131_9.htm EX-13.1




Webplus: SVA/20200430/20-F/9_EX-13.2/000.htm SEC Original: sva-ex132_12.htm
CERTIFICATION BY THE CHIEF FINANCIAL OFFICER (1) (2) Nan Wang Chief Financial Officer EX-13.2 9 sva-ex132_12.htm EX-13.2




Webplus: SVA/20200430/20-F/10_EX-15.1/000.htm SEC Original: sva-ex151_933.htm
Independent Registered Public Accounting Firm’s Consent We consent to the incorporation by reference in the Registration Statement of Sinovac Biotech Ltd. on Form S-8 (FILE NO. 333-161827) and Form S-8 (FILE NO. 333-190980) of our report dated April 30, 2020, with respect to our audit of the consolidated financial statements of Sinovac Biotech Ltd. Our report on the consolidated financial




Webplus: SVA/20200430/20-F/11_EX-15.2/000.htm SEC Original: sva-ex152_932.htm
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the following Registration Statements: i) Registration Statement (Form S-8 No. 333-161827) pertaining to Sinovac Biotech Ltd.’s 2003 Stock Option Plan; and ii) Registration Statement (Form S-8 No. 333-190980) pertaining to Sinovac Biotech Ltd.’s 2012 Share Incentive Plan; of our report dated May 11, 2018 (except



Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 20-F, Date: 2020-04-30, XBRL Interactive FinancialsCIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 15 ZHI TONG ROAD,, ZHONGGUANCUN TECH PARK, CHANGPING DISTR.
BEIJING 102200

Home Page Forums

By | 2020-10-01T15:39:46+00:00 April 30th, 2020|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

About the Author:

Leave A Comment

Skip to toolbar